12
views
0
recommends
+1 Recommend
1 collections
    0
    shares

      Call for Papers: Preclinical Investigations of Nutrigenetic/Nutrigenomic Targets

      Submit here before January 31, 2025

      About Lifestyle Genomics: 2.0 Impact Factor I 4.0 CiteScore I 0.539 Scimago Journal & Country Rank (SJR)

      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Increased Predictive Ability of BMI but not Other Risk Factors with Time in Men: 39-Year Follow-Up of Total Mortality in the Oslo Study

      research-article
      a , b
      Obesity Facts
      S. Karger AG
      BMI, Blood pressure, Cholesterol, Lipids, Mortality, Oslo Study, Physical activity, Smoking

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective: Risk factor associations to mortality may change, in part due to removal of high-risk persons. We compared strengths of association and ability of risk factors to predict total mortality across short (<15 years), medium (15-29 years) and long (30-39 years) follow-up. Methods: Cardiovascular risk factors were measured in 1972-1973 in the Oslo Study among 14,846 men born in 1923-1932. Relationships of risk factors to mortality (to 2011) were analyzed using Cox regression models, and receiver operating characteristics (ROC) were estimated. Results: BMI was the only factor that increased strength of association with elapsed time (hazard ratio for ≥35 kg/m<sup>2</sup> vs. 22.5-24.9 kg/m<sup>2</sup>: 1.25 (95% CI 0.73-2.17), 1.51 (95% CI 1.06-2.16) and 3.73 (95% CI 2.33-5.98) for <15, 15-29 and 30-39 years, respectively). Other factors lost predictive ability with time. Cigarette smoking was the strongest predictor in all periods. Serum lipids and systolic blood pressure increased risk in most periods, and moderate physical activity was protective to 29 years, but these factors and BMI contributed minimally to ROC. Discussion: Risk factors differed in association strengths and ability to predict mortality over four decades. BMI strengthened its association with time, while cigarette smoking was strongest in all periods.

          Related collections

          Most cited references40

          • Record: found
          • Abstract: not found
          • Article: not found

          Physiological analysis of middle-aged and old former athletes. Comparison with still active athletes of the same ages.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Cholesterol and mortality. 30 years of follow-up from the Framingham study.

            From 1951 to 1955 serum cholesterol levels were measured in 1959 men and 2415 women aged between 31 and 65 years who were free of cardiovascular disease (CVD) and cancer. Under age 50 years, cholesterol levels are directly related with 30-year overall and CVD mortality; overall death increases 5% and CVD death 9% for each 10 mg/dL. After age 50 years there is no increased overall mortality with either high or low serum cholesterol levels. There is a direct association between falling cholesterol levels over the first 14 years and mortality over the following 18 years (11% overall and 14% CVD death rate increase per 1 mg/dL per year drop in cholesterol levels). Under age 50 years these data suggest that having a very low cholesterol level improves longevity. After age 50 years the association of mortality with cholesterol values is confounded by people whose cholesterol levels are falling--perhaps due to diseases predisposing to death.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found

              Proportion of the decline in cardiovascular mortality disease due to prevention versus treatment: public health versus clinical care.

              Mortality rates from coronary heart disease (CHD), which had risen during the twentieth century in many countries, started declining in some countries during the 1960s. Once initial skepticism about the validity of the observed trends dissipated, researchers attempted to generate explanations about the events that had transpired using a variety of techniques, including ecological examinations of the trends in risk factors for CHD and changes in management of CHD, multivariate risk equations, and increasingly sophisticated modeling techniques. Improvements in risk factors as well as changes in cardiac treatments have both contributed to the reductions in CHD mortality, although estimates of their contributions have varied among countries. Models suggest that additional large reductions in CHD mortality are feasible by either improving the distribution of risk factors in the population or raising the percentage of patients receiving evidence-based treatments.
                Bookmark

                Author and article information

                Journal
                OFA
                OFA
                Obes Facts
                10.1159/issn.1662-4025
                Obesity Facts
                S. Karger AG
                1662-4025
                1662-4033
                2014
                October 2014
                09 October 2014
                : 7
                : 5
                : 311-321
                Affiliations
                aDepartment of Biostatistics, Epidemiology and Health Economics, Oslo University Hospital Ullevål, Oslo, Norway; bDepartment of Preventive Cardiology, Oslo University Hospital Ullevål, Oslo, Norway
                Article
                368567 Obes Facts 2014;7:311-321
                10.1159/000368567
                5644888
                25300406
                da4c8a29-e3a8-4247-9bcd-ad5f39bcddca
                © 2014 S. Karger GmbH, Freiburg

                Open Access License: This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) ( http://www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

                History
                : 22 January 2014
                : 26 May 2014
                Page count
                Pages: 11
                Categories
                Original Article

                Nutrition & Dietetics,Health & Social care,Public health
                Cholesterol,BMI,Mortality,Oslo Study,Physical activity,Smoking,Blood pressure,Lipids

                Comments

                Comment on this article